
Voyager Therapeutics
This company is dedicated to breaking through barriers in gene therapy and neurology.
Market cap
$163m
Enterprise value
($31m)
Share price
$3.11 VYGR
Authorizing premium user...
This company is dedicated to breaking through barriers in gene therapy and neurology.